Skip to main content

Table 6 Summary of simulated cumulative EC incidence and mortality among different screening strategies

From: Modeling the Cost-effectiveness of Esophageal Cancer Screening in China

Age Strategy CI (per 100,000) CM (per 100,000) RCI (%) RCM (%)
Scr* vs No_Scr Scr_fol vs Scr_nfol Scr* vs No_Scr Scr_fol vs Scr_nfol
40–44 Non_scr 1010.62 776.76
Scr_nfol 711.21 555.45 − 29.63 − 28.49
Scr_fol 708.61 553.32 − 29.88 − 0.37 − 28.77 − 0.38
45–49 Non_scr 1010.04 778.32
Scr_nfol 719.08 587.97 − 28.81 − 24.46
Scr_fol 708.81 579.22 − 29.82 − 1.43 − 25.58 − 1.49
50–54 Non_scr 994.97 766.49
Scr_nfol 726.70 642.84 − 26.96 − 16.13
Scr_fol 701.17 619.77 − 29.53 − 3.51 − 19.14 − 3.59
55–59 Non_scr 962.42 746.15
Scr_nfol 748.82 767.25 − 22.19 2.83
Scr_fol 691.03 709.45 − 28.20 − 7.72 − 4.92 − 7.53
60–64 Non_scr 857.84 649.89
Scr_nfol 720.35 829.78 − 16.03 27.68
Scr_fol 637.03 738.52 − 25.74 − 11.57 13.64 − 11.00
65–69 Non_scr 710.26 512.38
Scr_nfol 696.12 952.77 − 1.99 85.95
Scr_fol 576.12 806.34 − 18.89 − 17.24 57.37 − 15.37
  1. Scr_fol screening with follow-up, Scr_nfol screening without follow-up, Non_scr nonscreening, Scr* screening with or without follow-up, CI cumulative EC incidence, CM cumulative EC mortality, RCI reduction in cumulative incidence compared to an alternative strategy, RCM reduction in cumulative mortality compared to an alternative strategy
\